Announce Date | 04/30/2025 |
EPS Normalized Actual | $0.78 (Miss by $-0.12) |
EPS GAAP Actual | $0.78 (Miss by $-0.12) |
Revenue Actual | $1.35271B |
Revenue Surprise | Beat by $1352.71M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.48872 |
EPS GAAP Estimate | $0.48872 |
Revenue Estimate | $1.2990994B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.68 | 10.13 | 3.33984 | 4.29745 | 1 |
Dec 2028 | 3.98 | 9.36 | 3.69179 | 4.39991 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.67 | 0.67 | 1.35271B | 17.04% | 1352.71M |
FQ4 2024 (Dec 2024) | 0.16 | 0.16 | 1.22787B | -23% | 1227.87M |
FQ3 2024 (Sep 2024) | -0.0657 | -0.0657 | 1.05592B | -0.57% | 1055.92M |
FQ2 2024 (Jun 2024) | -0.21 | -0.21 | 0.978654B | 2.59% | 978.65M |
FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 1.12227B | 29.89% | 1122.27M |
FQ4 2023 (Dec 2023) | 1.15 | 1.15 | 1.51031B | 57.32% | 1510.31M |
FQ3 2023 (Sep 2023) | 0.06 | 0.06 | 1.06196B | -94.42% | 1061.96M |
FQ2 2023 (Jun 2023) | -0.43 | -0.43 | 0.953305B | -130.95% | 953.31M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.48872
Consensus Revenue Estimates
1.2990994B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.65 | -- | 1.43969 | 2.06505 | 8 |
FQ3 2027 (Sep 2027) | 1.11 | -- | 0.96852 | 1.38922 | 8 |
FQ2 2027 (Jun 2027) | 1.04 | -- | 0.90744 | 1.30161 | 8 |
FQ1 2027 (Mar 2027) | 1.19 | -- | 1.03832 | 1.48934 | 8 |
FQ4 2026 (Oct 2026) | 0.82535 | -- | 0.77863 | 0.86874 | 4 |
FQ3 2026 (Jul 2026) | 0.7614 | -- | 0.7183 | 0.80143 | 4 |
FQ2 2026 (Jun 2026) | 0.73395 | -- | 0.67301 | 0.84886 | 3 |
FQ1 2026 (Mar 2026) | 0.87599 | 23.52 | 0.80326 | 1.01314 | 6 |
FQ4 2025 (Oct 2025) | 0.63786 | 74.92 | 0.60175 | 0.67139 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.75B | -- | 1.58B | 2.09B | 3 |
FQ3 2027 (Sep 2027) | 1.68B | -- | 1.52B | 2.01B | 3 |
FQ2 2027 (Jun 2027) | 1.62B | -- | 1.46B | 1.93B | 3 |
FQ1 2027 (Mar 2027) | 1.56B | -- | 1.4B | 1.86B | 3 |
FQ4 2026 (Oct 2026) | 1.43B | -- | 1.37B | 1.49B | 4 |
FQ3 2026 (Jul 2026) | 1.43B | -- | 1.36B | 1.48B | 5 |
FQ2 2026 (Jun 2026) | 1.44B | -- | 1.34B | 1.61B | 5 |
FQ1 2026 (Mar 2026) | 1.44B | 5.73 | 1.34B | 1.61B | 6 |
FQ4 2025 (Oct 2025) | 1.37B | 10.38 | 1.31B | 1.43B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.67 | 0.67 | 100% | |
FQ4 2024 (Dec 2024) | 0.16 | 0.16 | 100% | |
FQ3 2024 (Sep 2024) | -0.0657 | -0.0657 | 100% | |
FQ2 2024 (Jun 2024) | -0.21 | -0.21 | 100% | |
FQ1 2024 (Mar 2024) | 0.12 | 0.12 | 100% | |
FQ4 2023 (Dec 2023) | 1.15 | 1.15 | 100% | |
FQ3 2023 (Sep 2023) | 0.06 | 0.06 | 100% | |
FQ2 2023 (Jun 2023) | -0.43 | -0.43 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.35B | $1352.71M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.23B | $1227.87M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.06B | $1055.92M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.98B | $978.65M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.12B | $1122.27M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.51B | $1510.31M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.06B | $1061.96M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.95B | $953.31M | 100% |